Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles.
To evaluate Dydrogesterone's effectiveness in PPOS protocols for IVF/ICSI or oocyte cryopreservation, focusing on LH surge suppression and metaphase II oocyte yield.
Optimizing infertility treatment for ovarian endometrioma: is surgical intervention preferable before or after in-vitro fertilization programs?
Endometriosis is one of the common endometrial pathologies that occurs in reproductive-age women and could lead to infertility. This study set out to observe which clinical management of endometriosis with …
Fertility preservation in women with endometriosis.
Endometriosis is a chronic disease that can compromise fertility in up to 30-50% of affected patients, and it is estimated that patients affected by endometriosis represent about 10% of patients …
The role of hysteroscopy in patients with adenomyosis and infertility: bringing out the submerged.
To describe how hysteroscopic treatment of adenomyotic cystic lesions of the innermyometrium, persisting after pharmacological treatment, can improve reproductive outcomes in patients with multiple IVF failures.